Omega Diagnostics Group Plc (LON:ODX)‘s stock had its “corporate” rating reissued by equities research analysts at FinnCap in a report issued on Monday. They currently have a GBX 28 ($0.34) price objective on the stock. FinnCap’s price target points to a potential upside of 49.33% from the company’s previous close.
Shares of Omega Diagnostics Group Plc (LON:ODX) opened at 18.50 on Monday. Omega Diagnostics Group Plc has a 12 month low of GBX 13.50 and a 12 month high of GBX 21.00. The company’s market cap is GBX 20.12 million. The stock’s 50 day moving average is GBX 16.99 and its 200-day moving average is GBX 16.82.
Omega Diagnostics Group Plc Company Profile
Omega Diagnostics Group PLC, based in the United Kingdom, is a holding company. The Company, along with its subsidiaries is engaged in manufacture, development and distribution of medical diagnostics products. The Company operates in three segments: Allergy and Autoimmune, Food Intolerance and Infectious Disease and Other.
Receive News & Ratings for Omega Diagnostics Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Diagnostics Group Plc and related companies with MarketBeat.com's FREE daily email newsletter.